Chapter 14

Rheumatologic and other autoimmune dementias

Laura J. Julian

Laura J. Julian

University of California, San Francisco, San Francisco, CA, USA

Search for more papers by this author
Christopher M. Filley

Christopher M. Filley

University of Colorado School of Medicine, Denver, CO, USA

Denver VA Medical Center, Denver, CO, USA

Search for more papers by this author
First published: 22 January 2016

Summary

Systemic lupus erythematosus (SLE) is the rheumatologic disease whose neuropsychiatric manifestations have received the most attention from both clinicians and researchers. This chapter first focuses on systemic lupus erythematosus and then discusses other rheumatic disorders with the propensity for producing neuropsychiatric sequelae, including the antiphospholipid antibody syndrome (APS), Sjögren's syndrome, the vasculitides, systemic sclerosis (scleroderma), sarcoidosis, and celiac disease. The use of laboratory studies for the diagnosis of rheumatologic conditions has become increasingly refined and remains a key feature of the diagnostic process. Neuropsychological testing in these patients may facilitate the identification of specific patterns of cognitive impairment, assisting patient care and providing clues to pathophysiology. Neurologic complications in many of these diseases are rare, and our knowledge regarding diagnosis, clinical and neuroradiological presentation, and management is largely derived from case reports and case series.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.